• Posted by:
• HIL Applied Medical
• No comments

HIL profiled in Start-Up Magazine HIL’s Shmuel Eisenmann and Sagi Brink-Danan spoke with Elsevier’s Bob Kronemyer about the promise of proton beam cancer radiotherapy, its current limitations, and the company’s vision to bring it to every eligible patient. Elsevier Business …

• Posted by:
• HIL Applied Medical
• No comments

HIL in the news – Israel Today HIL Co-founder Prof. Arie Zigler, and the technology the company is developing, were featured today in Israel’s newspaper Israel Today. “HIL’s most recent experimental results, as well as other advances in the fields …

• Posted by:
• HIL Applied Medical
• No comments

Mr. Yves Jongen joins HIL’s Advisory Board Yves Jongen is Chief Research Officer for Ion Beam Applications. After founding IBA in 1986, he served as general manager and co-general manager of the company until March 2000, when he assumed his …

• Posted by:
• HIL Applied Medical
• No comments

Prof. Zelig Tochner joins HIL’s Advisory Board Prof. Tochner is the medical director of the Roberts Proton Therapy Center at the University of Pennsylvania Medical Center, one of the world’s largest proton therapy facilities. He is also the chief of …

• Posted by:
• HIL Applied Medical
• No comments

Mr. Oded Tamir Joins HIL as Executive Chairman. Oded is the Co-Founder and, until recently, COO and Board Member of InSightec LTD – the worldwide leader in MRI-guided Focused Ultrasound Acoustic Surgery. He is an experienced C-level executive and board member with …

• Posted by:
• HIL Applied Medical
• No comments

New HIL technology peer-reviewed paper published Another peer-reviewed scientific paper was published today in the recent issue of PRL (Physical Review Letters) by HIL founders Prof. Arie Zigler and Dr. Shmuel Eisenmann, HIL physicist Mr. Eyal Gad Nahum, and their …

• Posted by:
• HIL Applied Medical
• No comments

HIL’s scientific poster accepted for presentation at PTCOG 52 in Essen, Germany HIL’s abstract – “Re-visiting laser-driven-protons as a viable route towards cost-effective proton therapy” – was accepted as a scientific poster. It will be presented at the 52nd Annual Conference …

• Posted by:
• HIL Applied Medical
• No comments

HIL receives US patent approval US Patent No. 8,389,954 – “System for Fast Ion Generation and a Method Thereof” – was approved by the USPTO, including all original claims. The patent application was filed by Yissum Research Development Company of …

• Posted by:
• HIL Applied Medical
• No comments

HIL among winners of the Life Science Companies Competition – BIO 2013 Chicago Winners were announced today for the  recent contest for Israeli Life Science companies, sponsored by MATIMOP with the Office of the Chief Scientist (OCS) at the Ministry of Industry, Trade …